Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Tenax Therapeutics, Inc.
13G/A
TENX · 88032L605
|
7.1% |
10/13/2026
Event 9/30/2026
|
|||
| Sphera Funds Management Ltd. | 7.1% | ||||
| Sphera Global Healthcare GP Ltd. | 7.1% | ||||
| Sphera Global Healthcare Management LP | 7.1% | ||||
|
ProMIS Neurosciences Inc.
13G/A
PMN · 74346M406
|
7.8% |
2/5/2026
Event 12/31/2025
|
|||
| Sphera Funds Management Ltd. | 7.8% | ||||
| Sphera Global Healthcare GP Ltd. | 7.8% | ||||
| Sphera Global Healthcare Management LP. | 7.8% | ||||
|
Outlook Therapeutics, Inc.
13G/A
OTLK · 69012T305
|
4.7% |
2/5/2026
Event 12/31/2025
|
|||
| Sphera Funds Management Ltd. | 4.7% | ||||
| Sphera Global Healthcare GP Ltd. | 4.7% | ||||
| Sphera Global Healthcare Management LP. | 4.7% | ||||
|
Skye Bioscience, Inc.
13G/A
SKYE · 83086J200
|
4.8% |
4/10/2025
Event 3/31/2025
|
|||
| Sphera Funds Management Ltd. | 4.8% | ||||
| Sphera Global Healthcare GP Ltd. | 4.8% | ||||
| Sphera Global Healthcare Management LP. | 4.8% | ||||
|
Chemomab Therapeutics Ltd.
13G/A
CMMB · 16385C104
|
4.8% |
4/10/2025
Event 3/31/2025
|
|||
| Sphera Funds Management Ltd. | 4.8% | ||||
| Sphera Global Healthcare GP Ltd. | 4.8% | ||||
| Sphera Global Healthcare Management LP. | 4.8% | ||||